Ad
Thursday, 5 October 2017
U.S. court reverses ban on sale of Regeneron, Sanofi cholesterol drug
(Reuters) - A U.S. appeals court on Thursday threw out a ban on the sale of Regeneron Pharmaceuticals Inc and Sanofi SA's cholesterol-lowering drug Praluent, and ordered a new trial after finding a jury was given improper instructions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment